Measuring, Modeling, and Forecasting the Mental Wealth of Nations.

gross domestic product (GDP) mental capital mental health policy analysis simulation systems modeling wellbeing

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 18 02 2022
accepted: 06 06 2022
entrez: 15 8 2022
pubmed: 16 8 2022
medline: 17 8 2022
Statut: epublish

Résumé

The COVID-19 pandemic has exposed the deep links and fragility of economic, health and social systems. Discussions of reconstruction include renewed interest in moving beyond GDP and recognizing "human capital", "brain capital", "mental capital", and "wellbeing" as assets fundamental to economic reimagining, productivity, and prosperity. This paper describes how the conceptualization of Mental Wealth provides an important framing for measuring and shaping social and economic renewal to underpin healthy, productive, resilient, and thriving communities. We propose a transdisciplinary application of systems modeling to forecast a nation's Mental Wealth and understand the extent to which policy-mediated changes in economic, social, and health sectors could enhance collective mental health and wellbeing, social cohesion, and national prosperity. Specifically, simulation will allow comparison of the projected impacts of a range of cross-sector strategies (education sector, mental health system, labor market, and macroeconomic reforms) on GDP and national Mental Wealth, and provide decision support capability for future investments and actions to foster Mental Wealth. Finally, this paper introduces the Mental Wealth Initiative that is harnessing complex systems science to examine the interrelationships between social, commercial, and structural determinants of mental health and wellbeing, and working to empirically challenge the notion that fostering universal social prosperity is at odds with economic and commercial interests.

Identifiants

pubmed: 35968431
doi: 10.3389/fpubh.2022.879183
pmc: PMC9368578
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

879183

Subventions

Organisme : Medical Research Council
ID : MR/S037578/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S037578/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00022/5
Pays : United Kingdom

Informations de copyright

Copyright © 2022 Occhipinti, Buchanan, Skinner, Song, Tran, Rosenberg, Fels, Doraiswamy, Meier, Prodan and Hickie.

Déclaration de conflit d'intérêts

JO is Co-Director of the Mental Wealth Initiative and Head of Systems Modelling, Simulation and Data Science at the University of Sydney's Brain and Mind Centre. She holds a non-salaried position as Managing Director of Computer Simulation and Advanced Research Technologies (CSART), a registered charity. She also serves on the World Economic Forum's Global Future Council on Mental Health. JB is Professor in the Discipline of Business Information Systems in the University of Sydney Business School. He is Co-Director of the Mental Wealth Initiative. He is also on the advisory board (voluntary) for two non-government organizations: (i) the People Development Council of Dairy Australia (the peak organization for dairy farmers and processes in Australia), and (ii) the Centre for Future Work. AF is Chair of Mind Australia (an NGO) and a Board Member of the Haven Foundation (an NGO). PD is Co-Chair of the World Economic Forum's Global Future Council on Mental Health and has received travel support from the World Economic Forum. He serves on the boards of Live Love Laugh Foundation and Goldie Hawn Foundation which work to enhance mental health. He has received the following: research grants from the NIH, DOD, Eli Lilly, Avanir, Avid, Cure Alzheimer's Fund, Karen L Wrenn Trust and Steve Aoki Foundation; advisory fees from Vitakey, Lumos Labs, Otsuka, Apollo, Transposon, Sermo, and Neuroglee; stock in Evidation Health and UMethod (whose products are not discussed here). His also co-inventor, through Duke, of patents for diagnosis or treatment of various disorders. AP holds a non-salaried position as an Independent Director of Computer Simulation and Advanced Research Technologies Ltd. (CSART), a registered charity. IH serves on the World Economic Forum's Global Future Council on Mental Health. He was an inaugural Commissioner on Australia's National Mental Health Commission (2012–18). He is Co-Director, Health and Policy at the Brain and Mind Centre (BMC), University of Sydney, Australia. The BMC operates an early-intervention youth services at Camperdown under contract to headspace. He is also the Chief Scientific Advisor to, and a 5% equity shareholder in, InnoWell Pty Ltd. InnoWell was formed by the University of Sydney (45% equity) and PwC (Australia; 45% equity) to deliver the $30M Australian Government-funded Project Synergy (2017–20; a 3-year program for the transformation of mental health services) and to lead transformation of mental health services internationally through the use of innovative technologies. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Front Psychiatry. 2019 Jul 02;10:448
pubmed: 31333513
Science. 2006 Jun 30;312(5782):1900-2
pubmed: 16809525
N Engl J Med. 1999 Dec 16;341(25):1892-8
pubmed: 10601509
J Nerv Ment Dis. 2005 Nov;193(11):705-13
pubmed: 16260923
Australas Psychiatry. 2016 Aug;24(4):331-6
pubmed: 26773063
Front Public Health. 2021 Feb 11;9:627559
pubmed: 33643992
Science. 2020 Dec 11;370(6522):
pubmed: 33303583
BMJ. 2019 Feb 6;364:l94
pubmed: 31339847
Sci Rep. 2021 May 27;11(1):11209
pubmed: 34045644
Health Econ Policy Law. 2008 Oct;3(Pt 4):321-31
pubmed: 18793475
Science. 2012 Nov 16;338(6109):887-8
pubmed: 23161980
Soc Sci Med. 2015 Mar;128:95-104
pubmed: 25596373
Schizophr Bull. 2012 Jun;38(4):661-71
pubmed: 22461484
Child Abuse Negl. 1998 Feb;22(2):79-90
pubmed: 9504211
Public Health Pract (Oxf). 2021 Nov;2:100143
pubmed: 34494009
Epidemiol Psychiatr Sci. 2020 Aug 18;29:e161
pubmed: 32807256
Am J Public Health. 2006 Mar;96(3):452-8
pubmed: 16449591
Proc Natl Acad Sci U S A. 2021 Jun 8;118(23):
pubmed: 34016707
BMC Public Health. 2007 Mar 07;7:30
pubmed: 17343754
J Epidemiol Community Health. 2021 Jan 5;:
pubmed: 33402397
Lancet Planet Health. 2020 Aug;4(8):e312-e314
pubmed: 32702296
Mol Psychiatry. 2021 Jan;26(1):3-22
pubmed: 33100330
Public Adm Rev. 2020 Sep-Oct;80(5):832-838
pubmed: 32836465
Milbank Q. 2021 Jun;99(2):467-502
pubmed: 33783865
Int J Environ Res Public Health. 2019 Feb 13;16(4):
pubmed: 30781815
J Public Health (Oxf). 2019 Jun 1;41(2):259-267
pubmed: 29992268
Psychiatr Clin North Am. 2008 Jun;31(2):223-35
pubmed: 18439446
BMJ. 2019 Nov 13;367:l5706
pubmed: 31722873
Global Health. 2020 Nov 19;16(1):112
pubmed: 33213482
CNS Drugs. 2005;19(4):313-24
pubmed: 15813645
Nature. 2014 Jan 16;505(7483):283-5
pubmed: 24436983
J Environ Health. 2018 Jun;80(10):34-36
pubmed: 32327766
Aust N Z J Psychiatry. 2019 Jul;53(7):642-650
pubmed: 30541332
JAMA Netw Open. 2021 Jan 4;4(1):e2036462
pubmed: 33512520
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Lancet Psychiatry. 2017 Jul;4(7):554-562
pubmed: 28552501
Eur Child Adolesc Psychiatry. 2015 Jun;24(6):641-50
pubmed: 24723042
JAMA Pediatr. 2013 Jul;167(7):622-9
pubmed: 23645114
Am J Prev Med. 2017 Oct;53(4):457-464
pubmed: 28501239
Lancet Psychiatry. 2015 Dec;2(12):1052-4
pubmed: 26613844
Sci Rep. 2021 Jan 21;11(1):1866
pubmed: 33479364
BMC Public Health. 2010 Sep 01;10:525
pubmed: 20809937
Front Psychiatry. 2021 Oct 13;12:759343
pubmed: 34721120
Int J Public Health. 2018 May;63(4):537-546
pubmed: 29051984
Lancet. 2013 Jun 8;381(9882):1970-1
pubmed: 23746771
J Epidemiol Community Health. 2021 Nov;75(11):1129-1132
pubmed: 34158408
Lancet Psychiatry. 2018 Apr;5(4):357-369
pubmed: 29580610
Lancet Psychiatry. 2017 Jul;4(7):512-513
pubmed: 28552499
Am J Public Health. 2006 Mar;96(3):505-14
pubmed: 16449579
Schizophr Bull. 1998;24(1):37-74
pubmed: 9502546
BMC Med. 2021 Mar 12;19(1):61
pubmed: 33706764
Nature. 2021 Sep;597(7878):633-636
pubmed: 34565800
Tob Control. 2021 Jan;30(1):77-83
pubmed: 31857491
Nature. 2008 Oct 23;455(7216):1057-60
pubmed: 18948946
Lancet Planet Health. 2017 May;1(2):e48-e49
pubmed: 29851576
Aust N Z J Psychiatry. 2020 Sep;54(9):892-901
pubmed: 32551878

Auteurs

Jo-An Occhipinti (JA)

Faculty of Medicine and Health, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.
Computer Simulation and Advanced Research Technologies, Sydney, NSW, Australia.

John Buchanan (J)

Mental Wealth Initiative, University of Sydney, Sydney, NSW, Australia.

Adam Skinner (A)

Faculty of Medicine and Health, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.

Yun Ju C Song (YJC)

Faculty of Medicine and Health, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.

Kristen Tran (K)

Faculty of Medicine and Health, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.

Sebastian Rosenberg (S)

Faculty of Medicine and Health, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.

Allan Fels (A)

Melbourne Institute of Applied Economic and Social Research, Melbourne Law School, University of Melbourne, Melbourne, VIC, Australia.

P Murali Doraiswamy (PM)

Departments of Psychiatry and Medicine, Duke University School of Medicine, Duke University, Durham, NC, United States.

Petra Meier (P)

Systems Science in Public Health, University of Glasgow, Glasgow, United Kingdom.

Ante Prodan (A)

Computer Simulation and Advanced Research Technologies, Sydney, NSW, Australia.
School of Computer, Data and Mathematical Sciences, Western Sydney University, Penrith, NSW, Australia.

Ian B Hickie (IB)

Faculty of Medicine and Health, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH